.png)
Drug Screening Market by Product & Service and Application - Global Industry Analysis & Forecast to 2027
Published On : May 2022 Pages : 180 Category: Biotechnology Report Code : HC053751
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Drug Screening Market By Product & Service (Equipment, Consumables, Rapid Testing Devices and Laboratory Services) and End User (Workplace and Schools, Law Enforcement Agencies, Drug Treatment Centers, Drug Testing Laboratories and Hospitals) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Drug screening test investigations organic examples, for example, blood, hair, and pee; to analyze the nearness of Drug misuse or its metabolites in patient's body. Drug screening tests are utilized to decide whether individual is or was under the impacts of medication at one point of time. Drug screening gadgets have improved attributable to presentation of new innovation; offering the clients exact and precise outcomes. Ascend in liquor utilization among youth just as older populace, abuse of endorsed drugs, increment being used of opiates and unlawful drugs is a noteworthy driver for the market.
Drivers and Restraints
The market has been witnessed developing with a rapid pace in the recent years due to the factors, for example, increasing interest for illegal drug or medication and liquor utilization, implementation of stringent laws ordering medication and liquor testing, and administrative endorsements and new item and administration dispatches are driving the development of the market.
Regional Insights
The strength of the North American market is ascribed to variables, for example, rising utilization of illegal drug, accessibility of government subsidizing to check medication misuse, and the nearness of laws supporting medication screening, and developing weight of mishaps because of perilous dimensions of liquor utilization.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Alere, Inc.
- Abbott Laboratories
- Biorad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Quest Diagnostics Incorporated
- Drägerwerk AG & Co. KGAA
- Hoffmann-La Roche AG
- Siemens AG
- Danaher Corporation
- Express Diagnostics International Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Drug Screening Market, By Product & Service, Estimates and Forecast, 2017-2027 ($Million)
o Equipment
o Consumables
o Rapid Testing Devices
o Laboratory Services
· Drug Screening Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Workplace and Schools
o Law Enforcement Agencies
o Drug Treatment Centers
o Drug Testing Laboratories
o Hospitals
· Drug Screening Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Alere, Inc.
o Abbott Laboratories
o Biorad Laboratories, Inc.
o Thermo Fisher Scientific, Inc.
o Quest Diagnostics Incorporated
o Drägerwerk AG & Co. KGAA
o Hoffmann-La Roche AG
o Siemens AG
o Danaher Corporation
o Express Diagnostics International Inc.
· Drug Screening Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Drug Screening Market, By Country
o U.S. Drug Screening Market
o Canada Drug Screening Market
o Mexico Drug Screening Market
o Europe
§ Europe Drug Screening Market, By Country
· Germany Drug Screening Market
o UK Drug Screening Market
o France Drug Screening Market
o Russia Drug Screening Market
o Italy Drug Screening Market
o Rest of Europe Drug Screening Market
o Asia-Pacific
§ Asia-Pacific Drug Screening Market, By Country
o China Drug Screening Market
o Japan Drug Screening Market
o South Korea Drug Screening Market
o India Drug Screening Market
o Southeast Asia Drug Screening Market
o Rest of Asia-Pacific Drug Screening Market
o South America
§ South America Drug Screening Market
o Brazil Drug Screening Market
o Argentina Drug Screening Market
o Columbia Drug Screening Market
o Rest of South America Drug Screening Market
o Middle East and Africa
§ Middle East and Africa Drug Screening Market
o Saudi Arabia Drug Screening Market
o UAE Drug Screening Market
o Egypt Drug Screening Market
o Nigeria Drug Screening Market
o South Africa Drug Screening Market
o Rest of MEA Drug Screening Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Drug Screening Market, By Product And Service
5.1. Introduction
5.2. Global Drug Screening Revenue and Market Share by Product And Service (2017-2027)
5.2.1. Global Drug Screening Revenue and Revenue Share by Product And Service (2017-2027)
5.3. Equipment
5.3.1. Global Equipment Revenue and Growth Rate (2017-2027)
5.4. Consumables
5.4.1. Global Consumables Revenue and Growth Rate (2017-2027)
5.5. Rapid Testing Devices
5.5.1. Global Rapid Testing Devices Revenue and Growth Rate (2017-2027)
5.6. Laboratory Services
5.6.1. Global Laboratory Services Revenue and Growth Rate (2017-2027)
6. Drug Screening Market, By End User
6.1. Introduction
6.2. Global Drug Screening Revenue and Market Share by End User (2017-2027)
6.2.1. Global Drug Screening Revenue and Revenue Share by End User (2017-2027)
6.3. Workplace and Schools
6.3.1. Global Workplace and Schools Revenue and Growth Rate (2017-2027)
6.4. Law Enforcement Agencies
6.4.1. Global Law Enforcement Agencies Revenue and Growth Rate (2017-2027)
6.5. Drug Treatment Centers
6.5.1. Global Drug Treatment Centers Revenue and Growth Rate (2017-2027)
6.6. Drug Testing Laboratories
6.6.1. Global Drug Testing Laboratories Revenue and Growth Rate (2017-2027)
6.7. Hospitals
6.7.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7. Drug Screening Market, By Region
7.1. Introduction
7.2. Global Drug Screening Revenue and Market Share by Regions
7.2.1. Global Drug Screening Revenue by Regions (2017-2027)
7.3. North America Drug Screening by Countries
7.3.1. North America Drug Screening Revenue and Growth Rate (2017-2027)
7.3.2. North America Drug Screening Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Drug Screening by Countries
7.4.1. Europe Drug Screening Revenue and Growth Rate (2017-2027)
7.4.2. Europe Drug Screening Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Drug Screening by Countries
7.5.1. Asia-Pacific Drug Screening Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Drug Screening Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Drug Screening by Countries
7.6.1. South America Drug Screening Revenue and Growth Rate (2017-2027)
7.6.2. South America Drug Screening Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Drug Screening by Countries
7.7.1. Middle East and Africa Drug Screening Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Drug Screening Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Alere, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Abbott Laboratories
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Biorad Laboratories, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Thermo Fisher Scientific, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Quest Diagnostics Incorporated
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Drägerwerk AG & Co. KGAA
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Hoffmann-La Roche AG
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Siemens AG
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Danaher Corporation
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Express Diagnostics International Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Drug Screening Market Forecast (2017-2027)
9.1. Global Drug Screening Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Drug Screening Market Forecast by Regions (2017-2027)
9.2.1. North America Drug Screening Market Forecast (2017-2027)
9.2.1.1. United States Drug Screening Market Forecast (2017-2027)
9.2.1.2. Canada Drug Screening Market Forecast (2017-2027)
9.2.1.3. Mexico Drug Screening Market Forecast (2017-2027)
9.2.2. Europe Drug Screening Market Forecast (2017-2027)
9.2.2.1. Germany Drug Screening Market Forecast (2017-2027)
9.2.2.2. France Drug Screening Market Forecast (2017-2027)
9.2.2.3. UK Drug Screening Market Forecast (2017-2027)
9.2.2.4. Russia Drug Screening Market Forecast (2017-2027)
9.2.2.5. Italy Drug Screening Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Drug Screening Market Forecast (2017-2027)
9.2.3. Asia-Pacific Drug Screening Market Forecast (2017-2027)
9.2.3.1. China Drug Screening Market Forecast (2017-2027)
9.2.3.2. Japan Drug Screening Market Forecast (2017-2027)
9.2.3.3. Korea Drug Screening Market Forecast (2017-2027)
9.2.3.4. India Drug Screening Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Drug Screening Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Drug Screening Market Forecast (2017-2027)
9.2.4. South America Drug Screening Market Forecast (2017-2027)
9.2.4.1. Brazil Drug Screening Market Forecast (2017-2027)
9.2.4.2. Argentina Drug Screening Market Forecast (2017-2027)
9.2.4.3. Columbia Drug Screening Market Forecast (2017-2027)
9.2.4.4. Rest of South America Drug Screening Market Forecast (2017-2027)
9.2.5. Middle East and Africa Drug Screening Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Drug Screening Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Drug Screening Market Forecast (2017-2027)
9.2.5.3. Egypt Drug Screening Market Forecast (2017-2027)
9.2.5.4. Nigeria Drug Screening Market Forecast (2017-2027)
9.2.5.5. South Africa Drug Screening Market Forecast (2017-2027)
9.2.5.6. Turkey Drug Screening Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Drug Screening Market Forecast (2017-2027)
9.3. Drug Screening Market Forecast by Product And Service (2017-2027)
9.3.1. Drug Screening Forecast by Product And Service (2017-2027)
9.3.2. Drug Screening Market Share Forecast by Product And Service (2017-2027)
9.4. Drug Screening Market Forecast by End User (2017-2027)
9.4.1. Drug Screening Forecast by End User (2017-2027)
9.4.2. Drug Screening Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Drug Screening Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Drug Screening Revenue and Revenue Share by Product And Service (2017-2018)
Figure Global Equipment Revenue and Growth Rate (2017-2018)
Figure Global Consumables Revenue and Growth Rate (2017-2018)
Figure Global Rapid Testing Devices Revenue and Growth Rate (2017-2018)
Figure Global Laboratory Services Revenue and Growth Rate (2017-2018)
Table Global Drug Screening Revenue and Revenue Share by End User (2017-2018)
Figure Global Workplace and Schools Revenue and Growth Rate (2017-2018)
Figure Global Law Enforcement Agencies Revenue and Growth Rate (2017-2018)
Figure Global Drug Treatment Centers Revenue and Growth Rate (2017-2018)
Figure Global Drug Testing Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Drug Screening Revenue by Regions (2017-2018)
Figure North America Drug Screening Growth Rate (2017-2018)
Figure North America Drug Screening Revenue and Growth Rate (2017-2018)
Figure North America Drug Screening by Countries (2017-2018)
Figure North America Drug Screening Revenue (Million USD) by Countries (2017-2018)
Figure United States Drug Screening Growth Rate (2017-2018)
Figure United States Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Drug Screening Growth Rate (2017-2018)
Figure Canada Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Drug Screening Growth Rate (2017-2018)
Figure Mexico Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Drug Screening Growth Rate (2017-2018)
Figure Europe Drug Screening Revenue and Growth Rate (2017-2018)
Figure Europe Drug Screening by Countries (2017-2018)
Figure Europe Drug Screening Revenue (Million USD) by Countries (2017-2018)
Figure Germany Drug Screening Growth Rate (2017-2018)
Figure Germany Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Drug Screening Growth Rate (2017-2018)
Figure France Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Drug Screening Growth Rate (2017-2018)
Figure UK Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Drug Screening Growth Rate (2017-2018)
Figure Russia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Drug Screening Growth Rate (2017-2018)
Figure Italy Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Drug Screening Growth Rate (2017-2018)
Figure Rest of Europe Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Drug Screening Growth Rate (2017-2018)
Figure Asia-Pacific Drug Screening Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Drug Screening by Countries (2017-2018)
Figure Asia-Pacific Drug Screening Revenue (Million USD) by Countries (2017-2018)
Figure China Drug Screening Growth Rate (2017-2018)
Figure China Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Drug Screening Growth Rate (2017-2018)
Figure Japan Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Drug Screening Growth Rate (2017-2018)
Figure Korea Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Drug Screening Growth Rate (2017-2018)
Figure India Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Drug Screening Growth Rate (2017-2018)
Figure Southeast Asia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Drug Screening Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Drug Screening Growth Rate (2017-2018)
Figure South America Drug Screening Revenue and Growth Rate (2017-2018)
Figure South America Drug Screening by Countries (2017-2018)
Figure South America Drug Screening Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Drug Screening Growth Rate (2017-2018)
Figure Brazil Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Drug Screening Growth Rate (2017-2018)
Figure Argentina Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Drug Screening Growth Rate (2017-2018)
Figure Columbia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Drug Screening Growth Rate (2017-2018)
Figure Rest of South America Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Drug Screening Growth Rate (2017-2018)
Figure Middle East and Africa Drug Screening Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Drug Screening by Countries (2017-2018)
Figure Middle East and Africa Drug Screening Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Drug Screening Growth Rate (2017-2018)
Figure Saudi Arabia Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Drug Screening Growth Rate (2017-2018)
Figure United Arab Emirates Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Drug Screening Growth Rate (2017-2018)
Figure Egypt Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Drug Screening Growth Rate (2017-2018)
Figure Nigeria Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Drug Screening Growth Rate (2017-2018)
Figure South Africa Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Drug Screening Growth Rate (2017-2018)
Figure Turkey Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Drug Screening Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Drug Screening Revenue (Millions USD) and Growth Rate (2017-2018)
Table Alere, Inc. Drug Screening Financial Overview
Table Abbott Laboratories Drug Screening Financial Overview
Table Biorad Laboratories, Inc. Drug Screening Financial Overview
Table Thermo Fisher Scientific, Inc. Drug Screening Financial Overview
Table Quest Diagnostics Incorporated Drug Screening Financial Overview
Table Drägerwerk AG & Co. KGAA Drug Screening Financial Overview
Table Hoffmann-La Roche AG Drug Screening Financial Overview
Table Siemens AG Drug Screening Financial Overview
Table Danaher Corporation Drug Screening Financial Overview
Table Express Diagnostics International Inc. Drug Screening Financial Overview
Figure Global Drug Screening Revenue (Millions USD) and Growth Rate (2018-2025)
Table Drug Screening Market Forecast by Regions (2018-2025)
Figure North America Drug Screening Market Forecast (2018-2025)
Figure United States Drug Screening Market Forecast (2018-2025)
Figure Canada Drug Screening Market Forecast (2018-2025)
Figure Mexico Drug Screening Market Forecast (2018-2025)
Figure Europe Drug Screening Market Forecast (2018-2025)
Figure Germany Drug Screening Market Forecast (2018-2025)
Figure France Drug Screening Market Forecast (2018-2025)
Figure UK Drug Screening Market Forecast (2018-2025)
Figure Russia Drug Screening Market Forecast (2018-2025)
Figure Italy Drug Screening Market Forecast (2018-2025)
Figure Rest of Europe Drug Screening Market Forecast (2018-2025)
Figure Asia-Pacific Drug Screening Market Forecast (2018-2025)
Figure China Drug Screening Market Forecast (2018-2025)
Figure Japan Drug Screening Market Forecast (2018-2025)
Figure Korea Drug Screening Market Forecast (2018-2025)
Figure India Drug Screening Market Forecast (2018-2025)
Figure Southeast Asia Drug Screening Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Drug Screening Market Forecast (2018-2025)
Figure South America Drug Screening Market Forecast (2018-2025)
Figure Brazil Drug Screening Market Forecast (2018-2025)
Figure Argentina Drug Screening Market Forecast (2018-2025)
Figure Columbia Drug Screening Market Forecast (2018-2025)
Figure Rest of South America Drug Screening Market Forecast (2018-2025)
Figure Middle East and Africa Drug Screening Market Forecast (2018-2025)
Figure Saudi Arabia Drug Screening Market Forecast (2018-2025)
Figure United Arab Emirates Drug Screening Market Forecast (2018-2025)
Figure Egypt Drug Screening Market Forecast (2018-2025)
Figure Nigeria Drug Screening Market Forecast (2018-2025)
Figure South Africa Drug Screening Market Forecast (2018-2025)
Figure Turkey Drug Screening Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Drug Screening Market Forecast (2018-2025)
Figure Global Drug Screening Forecast by Product And Service (2018-2025)
Figure Global Drug Screening Market Share Forecast by Product And Service (2018-2025)
Figure Global Drug Screening Forecast by Product And Service (2018-2025)
Figure Global Drug Screening Forecast by End User (2018-2025)
Figure Global Drug Screening Market Share Forecast by End User (2018-2025)
Figure Global Drug Screening Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|